Breaks Categories: Stock Spotlights

ThursdaySep 06, 2018 11:14 am

CannabisNewsBreaks – BLOCKStrain Technology Corp. (TSX.V: DNAX) Innovative Platform Delivers IP Tracking to the Cannabis Industry

BLOCKStrain Technology (TSX.V: DNAX) is providing the first integrated blockchain platform that registers and tracks intellectual property (“IP”) for the cannabis industry. A recent article discussing the company’s innovative platform reads: “The chance to be part of this lucrative market presents an irresistible opportunity, and BLOCKStrain offers the ability to register and track cannabis intellectual property (IP) from “genome to sale,” providing unprecedented benefits to everyone involved, from the cultivation and processing to the sale and use of the plant. … Using BLOCKStrain, growers can identify and protect the different strains of cannabis they develop, establishing irrevocable rights to their…

Continue Reading

FridayAug 31, 2018 2:45 pm

CannabisNewsBreaks – Sunniva (CSE: SNN) (OTCQX: SNNVF) Considered Undervalued by Investment Researchers

Sunniva (CSE: SNN) (OTCQX: SNNVF) was recently covered in a publication by Beacon Securities Limited that argued that Sunniva is significantly undervalued. An article further discussing the company reads: “Cannabis supplier Sunniva Inc.’s (CSE: SNN) (OTCQX: SNNVF) strengthening foothold in California’s and Canada’s consumer-populated markets has been failing to translate to its stock price and market cap since it began trading on the Canadian Securities Exchange and the U.S. OTCQX® Best Market in January, leading investment researchers at Beacon Securities Limited (http://cnw.fm/PhE2A) to classify Sunniva’s public offering as a “badly mispriced” listing that could reward investors who buy in at…

Continue Reading

FridayAug 31, 2018 11:04 am

CannabisNewsBreaks – PreveCeutical Medical Inc.’s (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Developmental Pipeline Houses Comprehensive Range of Advanced Therapeutic Products

Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) holds a wide array of advanced therapeutic products in its development pipeline, including its Sol-gel delivery platform. The Sol-gel nose-to-brain drug delivery platform delivers a therapeutic compound to a targeted site at a deliberate, controlled rate. A recent article further discussing the company reads: “The Sol-gel platform allows a therapeutic agent to be administered via the nostrils, where it changes rapidly to a gel upon contact with mucosal tissue. The gel, which continues to line the nasal passage for up to seven days, slowly releases the therapeutic agent over…

Continue Reading

MondayAug 27, 2018 11:42 am

CannabisNewsBreaks – Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Gearing up for Launch of OKI Brand in 3Q2018

Phivida Holdings (CSE: VIDA) (OTCQX: PHVAF), a premium food and beverage company, is preparing to launch its OKI brand of premium CBD products to consumers during the third quarter of 2018. The company recently gained exposure to roughly 2,400 mainstream retail outlets across the U.S. by signing an exclusive national agreement with National Specialty Sales (“NSS”), an Acosta company. An article discussing the agreement reads: “The partnership also provides the opportunity to access an additional 25,000 national grocery supermarkets such as Wal-Mart, Target, Kroger and others in Acosta’s national sales network. PHVAF and Acosta are working together to develop in-store…

Continue Reading

FridayAug 24, 2018 3:02 pm

CannabisNewsBreaks – Sunniva (CSE: SNN) (OTCQX: SNNVF) Stands Out Among Potential Leading Compliant Producers in California Cannabis Market

Sunniva (CSE: SNN) (OTCQX: SNNVF) stands out among the emerging largest compliant producers with a vertically integrated business model and commitment to delivering safe, consistent, high-quality products and services. An article discussing the company reads, “In an executive summary of Sunniva’s market potential, Canaccord Genuity states, ‘Sunniva could become one of the larger compliant producers in California heading into 2019 where more than 85 percent of product is still not in compliance with current regulations.’ The company’s strategy of placing a high degree of importance on designing its facilities with innovative technologies that allow for automation, low-cost cultivation and the…

Continue Reading

FridayAug 24, 2018 12:36 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Human Clinical Study Confirms Significant Delivery, Bioavailability Results

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) is pleased with recent significant results from a new human clinical study to evaluate its DehydraTECH™ powered TurboCBD™ and cannabidiol (CBD) fortified hemp oil capsules (http://cnw.fm/2NCrW). An article discussing this reads, “Results corroborate and confirm earlier in vitro and in vivo studies that evaluated DehydraTECH’s platform and measured higher levels of drug delivery achieved quicker than controls with matching CBD amounts. LXRP said that it believes nearly identical bioavailability enhancement results would be shown if the cannabinoid was THC instead of CBD.” To view the full article, visit http://cnw.fm/Dwp1Q About Lexaria Bioscience Corp. Lexaria…

Continue Reading

WednesdayAug 15, 2018 2:29 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Technology Continues to Demonstrate Versatility

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) is the developer of a disruptive drug delivery platform, DehydraTECH™, that the company out-licenses to entities aiming to deliver healthier ingestion methods of cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. An article discussing the company’s technology reads: “Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) patented DehydraTECH™ drug delivery platform has already received some eight patents granted and nearly 50 pending worldwide, and the company has applied for one more to the USPTO. This is because, in lab studies, the proprietary technology has shown evidence of transporting active pharmaceutical ingredients (APIs) across…

Continue Reading

MondayAug 13, 2018 12:13 pm

CannabisNewsBreaks – BLOCKStrain Technology Corp. (TSX.V: DNAX) Opening Floodgates for Pending Launch of Disruptive Platform

BLOCKStrain Technology (TSX.V: DNAX) is reaching key milestones in the on-boarding of Licensed Producers (“LPs”) and testing partners for use of its disruptive seed-to-sale platform. Speaking of the strategic accomplishment, Chief Technology Officer Tommy Stephenson states, “Getting the on-boarding process protocols completed was mission critical. This milestone opens the floodgates for the whole ecosystem we have designed. BLOCKStrain’s partners – LPs, testing facilities, labs – can now quickly and efficiently link into our integrated platform without disturbing their core business processes.” To view the full article, visit http://cnw.fm/8uPfX About BLOCKStrain Technology Corp. BLOCKStrain Technology Corp. has developed the first integrated…

Continue Reading

FridayAug 10, 2018 3:05 pm

CannabisNewsBreaks – Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) to Provide Ultra-Purified Cannabis Extracts Through White Label Agreement

Sunniva (CSE: SNN) (OTCQX: SNNVF) has penned a white label services agreement to provide Cannabis Strategic Ventures, Inc. (OTC: NUGS) with top-quality cannabis extracts for its Pure Organix™ brand. In discussing the venture, Sunniva CEO Tony Holler stated, “As one of the highest quality producers in the marketplace, we believe we are in an excellent position to provide brand product manufacturing services for Cannabis Strategic. Both of our firms share the vision of becoming leaders in providing clean, medical grade cannabis products to consumers.” To view the full article, visit http://cnw.fm/9hK1r About Cannabis Strategic Ventures, Inc. Cannabis Strategic Ventures is…

Continue Reading

FridayAug 10, 2018 11:57 am

CannabisNewsBreaks – Why Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) is “One to Watch”

Phivida Holdings (CSE: VIDA) (OTCQX: PHVAF) is a premium food and beverage company that develops foods, beverages and supplements infused with cannabidiol (“CBD”) for global distribution. An article discussing the company reads: “Using encapsulation technology, Phivida uses full spectrum CBD-hemp oil (rich in naturally occurring phytocannabinoids) converted into a water-soluble delivery format, which enhances delivery and absorption of the cannabinoids into the human body – up to an estimated tenfold. … Encapsulated CBD is infused into functional beverages, food and supplements containing a proprietary blend of phytonutraceuticals studied to target a range of health and wellness conditions. Phivida tests every…

Continue Reading